Implantable and wearable drug-delivery systems

Why how a medicine is delivered matters

The way a drug enters the body shapes how well it works and how it feels to take. A tablet taken a few times a day produces peaks and troughs: levels surge after each dose and fade before the next, which can mean side effects at the peak and weaker effect at the trough. Some medicines are broken down in the stomach or liver before they can act, and others need to reach one particular place in the body. On top of this, remembering to take medicines regularly is genuinely hard, and missed doses undermine treatment. Drug-delivery systems aim to fix these problems by releasing medicine steadily, protecting it from being destroyed, or targeting it where it is needed.

Implantable systems: steady release under the skin

Implantable systems place a small device or depot of medicine inside the body, often just under the skin, where it releases the drug slowly over weeks, months or years. A familiar UK example is the contraceptive implant, a tiny rod placed under the skin of the upper arm that steadily releases a hormone for up to three years. Similar long-acting injections and implants are used for some mental health conditions and hormone treatments, helping people who find daily tablets difficult. Some implants are designed to be refilled or removed when treatment ends. The main advantages are convenience and steady drug levels; the trade-offs include needing a small procedure to insert or remove them and, occasionally, local reactions at the site.

Wearable systems: patches and pumps

Wearable systems deliver medicine from outside the body. Skin patches release a drug slowly through the skin into the bloodstream, avoiding the gut and giving smooth, steady levels; familiar examples include nicotine patches to help stop smoking, hormone patches, and patches for some forms of long-term pain. Pumps go a step further by actively delivering medicine at a controlled rate. Insulin pumps, widely used in the UK for diabetes, deliver insulin continuously and allow extra doses at mealtimes, offering far finer control than injections alone. Because they are worn rather than implanted, these systems are easy to start and stop, but they must be applied or worn correctly, and patches can sometimes irritate the skin.

Smart and responsive delivery

The most exciting frontier is delivery that responds to the body in real time. In diabetes, so-called closed-loop or artificial pancreas systems combine a continuous glucose sensor with an insulin pump and a clever algorithm, automatically adjusting insulin to keep blood sugar in range with far less effort from the person — technology now reaching NHS patients. Researchers are developing implants that release medicine only when triggered, materials that respond to changes in the body such as temperature or chemistry, and tiny sensors that report back wirelessly. The goal is treatment that adapts moment to moment, giving exactly the right amount of drug at the right time. Much of this is still experimental, but the direction of travel towards responsive, personalised delivery is clear.

Benefits, challenges and the road ahead

The potential benefits of these systems are substantial: steadier drug levels, fewer doses to remember, treatment targeted where it is needed, and, for smart systems, care that adjusts automatically. This can improve both how well treatment works and quality of life. But there are real challenges. Devices must be safe, reliable and comfortable over long periods, guard against delivering too much or too little, and resist infection where they enter the body. They cost more than tablets and need careful regulation, and not everyone wants a device in or on their body. As with any advance, claims should be judged on solid evidence. Even so, drug delivery is quietly transforming how some of medicine's oldest problems are solved.